Excess α-synuclein compromises phagocytosis in iPSC-derived macrophages.
To examine the pathogenic role of α-synuclein (αS) in Parkinson's Disease, we have generated induced Pluripotent Stem Cell lines from early onset Parkinson's Disease patients with SNCA A53T and SNCA Triplication mutations, and in this study have differentiated them to PSC-macrophages (pMac...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Nature Publishing Group
2017
|
| Subjects: |
| _version_ | 1826273628129329152 |
|---|---|
| author | Haenseler, W Zambon, F Lee, H Vowles, J Rinaldi, F Duggal, G Houlden, H Gwinn, K Wray, S Luk, K Wade-Martins, R James, W Cowley, S |
| author_facet | Haenseler, W Zambon, F Lee, H Vowles, J Rinaldi, F Duggal, G Houlden, H Gwinn, K Wray, S Luk, K Wade-Martins, R James, W Cowley, S |
| author_sort | Haenseler, W |
| collection | OXFORD |
| description | To examine the pathogenic role of α-synuclein (αS) in Parkinson's Disease, we have generated induced Pluripotent Stem Cell lines from early onset Parkinson's Disease patients with SNCA A53T and SNCA Triplication mutations, and in this study have differentiated them to PSC-macrophages (pMac), which recapitulate many features of their brain-resident cousins, microglia. We show that SNCA Triplication pMac, but not A53T pMac, have significantly increased intracellular αS versus controls and release significantly more αS to the medium. SNCA Triplication pMac, but not A53T pMac, show significantly reduced phagocytosis capability and this can be phenocopied by adding monomeric αS to the cell culture medium of control pMac. Fibrillar αS is taken up by pMac by actin-rearrangement-dependent pathways, and monomeric αS by actin-independent pathways. Finally, pMac degrade αS and this can be arrested by blocking lysosomal and proteasomal pathways. Together, these results show that macrophages are capable of clearing αS, but that high levels of exogenous or endogenous αS compromise this ability, likely a vicious cycle scenario faced by microglia in Parkinson's disease. |
| first_indexed | 2024-03-06T22:31:06Z |
| format | Journal article |
| id | oxford-uuid:584ca9e8-2170-4293-a44f-b75e37c17825 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T22:31:06Z |
| publishDate | 2017 |
| publisher | Nature Publishing Group |
| record_format | dspace |
| spelling | oxford-uuid:584ca9e8-2170-4293-a44f-b75e37c178252022-03-26T17:02:28ZExcess α-synuclein compromises phagocytosis in iPSC-derived macrophages.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:584ca9e8-2170-4293-a44f-b75e37c17825*subject*EnglishSymplectic Elements at OxfordNature Publishing Group2017Haenseler, WZambon, FLee, HVowles, JRinaldi, FDuggal, GHoulden, HGwinn, KWray, SLuk, KWade-Martins, RJames, WCowley, STo examine the pathogenic role of α-synuclein (αS) in Parkinson's Disease, we have generated induced Pluripotent Stem Cell lines from early onset Parkinson's Disease patients with SNCA A53T and SNCA Triplication mutations, and in this study have differentiated them to PSC-macrophages (pMac), which recapitulate many features of their brain-resident cousins, microglia. We show that SNCA Triplication pMac, but not A53T pMac, have significantly increased intracellular αS versus controls and release significantly more αS to the medium. SNCA Triplication pMac, but not A53T pMac, show significantly reduced phagocytosis capability and this can be phenocopied by adding monomeric αS to the cell culture medium of control pMac. Fibrillar αS is taken up by pMac by actin-rearrangement-dependent pathways, and monomeric αS by actin-independent pathways. Finally, pMac degrade αS and this can be arrested by blocking lysosomal and proteasomal pathways. Together, these results show that macrophages are capable of clearing αS, but that high levels of exogenous or endogenous αS compromise this ability, likely a vicious cycle scenario faced by microglia in Parkinson's disease. |
| spellingShingle | *subject* Haenseler, W Zambon, F Lee, H Vowles, J Rinaldi, F Duggal, G Houlden, H Gwinn, K Wray, S Luk, K Wade-Martins, R James, W Cowley, S Excess α-synuclein compromises phagocytosis in iPSC-derived macrophages. |
| title | Excess α-synuclein compromises phagocytosis in iPSC-derived macrophages. |
| title_full | Excess α-synuclein compromises phagocytosis in iPSC-derived macrophages. |
| title_fullStr | Excess α-synuclein compromises phagocytosis in iPSC-derived macrophages. |
| title_full_unstemmed | Excess α-synuclein compromises phagocytosis in iPSC-derived macrophages. |
| title_short | Excess α-synuclein compromises phagocytosis in iPSC-derived macrophages. |
| title_sort | excess α synuclein compromises phagocytosis in ipsc derived macrophages |
| topic | *subject* |
| work_keys_str_mv | AT haenselerw excessasynucleincompromisesphagocytosisinipscderivedmacrophages AT zambonf excessasynucleincompromisesphagocytosisinipscderivedmacrophages AT leeh excessasynucleincompromisesphagocytosisinipscderivedmacrophages AT vowlesj excessasynucleincompromisesphagocytosisinipscderivedmacrophages AT rinaldif excessasynucleincompromisesphagocytosisinipscderivedmacrophages AT duggalg excessasynucleincompromisesphagocytosisinipscderivedmacrophages AT houldenh excessasynucleincompromisesphagocytosisinipscderivedmacrophages AT gwinnk excessasynucleincompromisesphagocytosisinipscderivedmacrophages AT wrays excessasynucleincompromisesphagocytosisinipscderivedmacrophages AT lukk excessasynucleincompromisesphagocytosisinipscderivedmacrophages AT wademartinsr excessasynucleincompromisesphagocytosisinipscderivedmacrophages AT jamesw excessasynucleincompromisesphagocytosisinipscderivedmacrophages AT cowleys excessasynucleincompromisesphagocytosisinipscderivedmacrophages |